Interestingly, levels of PROS1 in the plasma of patients with mild or severe COVID-19 showed no difference, suggesting that it is lung-produced PROS1 rather than systemic PROS1 that might regulate disease severity [24]. This evidence concerns the gene PROS1 and COVID-19.